Wells Fargo & Company Ishares Tr Genomics Immunology Transaction History
Wells Fargo & Company
- $507 Billion
- Q3 2025
A detailed history of Wells Fargo & Company transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Wells Fargo & Company holds 16,572 shares of IDNA stock, worth $432,694. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,572
Previous 14,934
10.97%
Holding current value
$432,694
Previous $306,000
27.78%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding IDNA
# of Institutions
60Shares Held
2.11MCall Options Held
0Put Options Held
0-
Ubs Group Ag560KShares$14.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC288KShares$7.52 Million0.0% of portfolio
-
Wharton Business Group, LLC Malvern, PA286KShares$7.46 Million0.29% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL148KShares$3.87 Million0.0% of portfolio
-
Portland Global Advisors LLC103KShares$2.69 Million0.27% of portfolio